Aquestive Therapeutics, Inc. · NASDAQ:AQST
BlackRock, Inc. reported a 6.40% stake in Aquestive Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Jul 27, 2026
BlackRock, Inc. reported a 6.40% stake in Aquestive Therapeutics, Inc., 7,992,647 shares, as a passive investor on Jun 30, 2026. Filed Jul 27, 2026 (Schedule 13G/A).
- Stake
- 6.40%
- Shares
- 7,992,647
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 6.40% | 7,992,647 |
Source
Related
- Aquestive Therapeutics, Inc.
- BlackRock, Inc.
- Aquestive Therapeutics, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Oct 17, 2025
- Form 4 · Barber Daniel · Oct 16, 2026
- Schedule 13G · Bass Edward P · Oct 7, 2026
- Schedule 13G/A · Bratton Douglas K · Oct 7, 2026
- Form 4 · Barber Daniel · Sep 16, 2026
- Form 4 · Korczynski Sherry · Sep 11, 2026